| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |